Expertise in
8
conditions

Lingli X. Dong

No. 1095 Jiefang Road, 
Wuhan, CN 
Expertise in
8
conditions
No. 1095 Jiefang Road, 
Wuhan, CN 

Overview

Lingli Dong practices practicing medicine in Wuhan, China.

Dong is highly rated in 8 conditions, according to our data. Their clinical expertise encompasses IgG4-Related Disease, Dry Mouth, Sjogren Syndrome, and Dry Eye Syndrome.

They are actively involved in clinical research, co-authoring 145 peer reviewed articles and participating in 1 clinical trial.

Locations

No. 1095 Jiefang Road, Wuhan, 430030, China
Other Locations
Jiefang Avenue 1095, Wuhan, 430030, China
No. 1095 Jiefang Avenue, Wuhan, 430030, China
1095th Jiefang Avenue, Wuhan, 430000, China
Union Hospital, Wuhan, 430022, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Biological
Study Drugs: Otilimab, Tofacitinib, csDMARDs
Study Phase: Phase 3

145 Total Publications

Invasive aspergillosis in autoimmune inflammatory rheumatic diseases: epidemiology, risk factors, diagnosis, management and challenges.
Invasive aspergillosis in autoimmune inflammatory rheumatic diseases: epidemiology, risk factors, diagnosis, management and challenges.
Journal: Annals of medicine
Published: June 25, 2026

Frequently Asked Questions about Lingli X. Dong

Is Lingli X. Dong a top-rated expert for IgG4-Related Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Lingli X. Dong is classified as an Distinguished expert for IgG4-Related Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Lingli X. Dong participate in research or clinical trials?

Yes. Lingli X. Dong has published 145 articles and abstracts on conditions like IgG4-Related Disease. You can view a list of Lingli X. Dong's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dong's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 36 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile